UBS AG Standalone Financial Summary (Year Ended Dec 31, 2018)
Business Context and Reporting Period
This Form 6-K contains the audited standalone financial statements for UBS AG for the year ended December 31, 2018. UBS AG is a regulated bank in Switzerland and a wholly-owned subsidiary of UBS Group AG. The reporting period marks a significant transition as UBS AG changed its functional and presentation currency from Swiss Francs (CHF) to US Dollars (USD) effective October 1, 2018. The entity primarily serves as a funding and investment hub for the Group, holding investments in subsidiaries and managing Group Asset and Liability Management (ALM) functions.
Key Financial Metrics
| Metric (USD Million) | 2018 | 2017 |
|---|---|---|
| Total Operating Income | 12,040 | 10,563 |
| Operating Profit | 2,501 | 472 |
| Net Profit | 3,333 | 932 |
| Total Assets | 480,238 | 489,313 |
| Total Liabilities | 429,130 | 438,074 |
| Total Equity | 51,107 | 51,239 |
| CET1 Capital Ratio (Basel III) | 16.87% | 17.43% |
| Liquidity Coverage Ratio (LCR) | 139% | 132% |
Material Changes vs. Prior Period
- Profitability Surge: Net profit increased significantly to USD 3.33 billion from USD 0.93 billion in 2017. This was driven by a substantial increase in dividend income from subsidiaries (USD 3.71 billion vs. USD 1.29 billion) and higher net trading income (USD 4.44 billion vs. USD 3.27 billion).
- Expense Reduction: Total operating expenses decreased to USD 9.54 billion from USD 10.09 billion. Personnel expenses dropped to USD 3.46 billion (from USD 4.23 billion) and general/administrative expenses fell to USD 4.21 billion (from USD 4.67 billion), largely due to the transfer of shared services functions to Group service companies in 2017.
- Impairment Charges: Impairment of investments in subsidiaries increased to USD 760 million (from USD 274 million), including a USD 276 million charge related to the increased stake in UBS Securities China.
- Balance Sheet Shifts: Total assets decreased slightly by USD 9 billion. Trading portfolio assets declined to USD 95.6 billion from USD 107.4 billion. Bonds issued decreased to USD 83.7 billion from USD 99.1 billion.
- Currency Conversion: Financial statements were translated to USD. Comparative 2017 figures are restated at the closing rate of Dec 31, 2017.
Guidance, Outlook, and Risks
- Dividend Proposal: The Board proposes an ordinary dividend distribution of USD 3.25 billion. The total CHF dividend is capped at CHF 4.062 billion; if the USD amount exceeds this cap based on the AGM exchange rate, the USD dividend will be reduced pro-rata.
- Regulatory Capital: UBS AG remains well-capitalized under Swiss SRB requirements. The CET1 ratio stood at 16.87% against a minimum requirement of 10.07%. The Leverage Ratio was 9.92% against a requirement of 3.5%.
- Post-Balance Sheet Events: The merger of UBS Limited into UBS Europe SE was formally concluded on March 1, 2019. This resulted in a reduction of the 2018 impairment loss on UBS Limited by USD 0.2 billion. Additionally, provisions for litigation and regulatory matters were adjusted by USD 340 million based on events after the reporting period.
- Risks: Significant contingent liabilities include guarantees to third parties related to subsidiaries (USD 7.48 billion) and irrevocable loan commitments (USD 25.02 billion). The entity is jointly and severally liable for the VAT of the UBS VAT group in Switzerland.
Investor Verification Checklist
- Dividend Cap Mechanics: Verify the exchange rate on the AGM date (April 18, 2019) to determine if the USD 3.25 billion dividend will be reduced to meet the CHF 4.062 billion cap.
- Impairment Reversal: Confirm the impact of the March 2019 merger on the 2018 impairment charge for UBS Limited (USD 0.2 billion reduction).
- Related Party Exposure: Review the significant funding received from UBS Group AG (USD 41.78 billion) and UBS Group Funding (Switzerland) AG, which constitutes a major portion of liabilities.
- Currency Translation: Ensure analysis accounts for the functional currency change from CHF to USD effective October 1, 2018, which impacts comparability of certain line items.
- Regulatory Buffers: Monitor the phase-in of IFRS 9 expected credit loss (ECL) effects on CET1 capital, which UBS opted to phase in over five years starting Dec 31, 2018.